Alembic Pharma gets tentative USFDA nod for Selexipag injection
The drug major on Friday announced that it has received a tentative approval from the US Food & Drug Administration (USFDA) for its abbreviated new drug application (ANDA) Selexipag for injection, 1,800 mcg/vial.